Status:
COMPLETED
CMR Features in Patients With Suspected Myocarditis
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Outcome, Fatal
Eligibility:
All Genders
18+ years
Brief Summary
Presentation of myocarditis is heterogeneous, often ranges from being asymptomatic, to chest pain, dyspnoea, palpitations, and even sudden cardiac death. Diagnosing myocarditis is challenging with no ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients referred by their treating physician to undergo CMR for "suspected myocarditis" as the primary clinical question
- Exclusion criteria
- evidence of coronary artery disease
- hypertrophic cardiomyopathy
- arrhythmogenic right ventricular cardiomyopathy
- cardiac sarcoidosis
- cardiac amyloidosis
- takotsubo cardiomyopathy
- constrictive pericarditis
- Loeffler endocarditis
- ventricular non-compaction
- cardiac tumor
- pulmonary embolism
- severe valve disease
Exclusion
Key Trial Info
Start Date :
June 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
670 Patients enrolled
Trial Details
Trial ID
NCT03470571
Start Date
June 1 2016
End Date
February 1 2018
Last Update
March 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital, Shapiro Cardiovascular Center
Boston, Massachusetts, United States, 02115